| Journal of Neuroinflammation | |
| Antibodies to the inositol 1,4,5-trisphosphate receptor type 1 (ITPR1) in cerebellar ataxia | |
| Lars Komorowski5  Brigitte Wildemann3  Dimitri Psimaras1  Francesc Graus6  Sigrun Nagel2  Irina I Serysheva4  Christian Probst5  Winfried Stöcker5  Nora Begemann5  Madeleine Scharf5  Sven Jarius3  | |
| [1] Department of Neurology Mazarin, Hôpital Pitié-Salpêtrière, University René Descartes, 47-83, Boulevard de l’Hôpital, Paris, 75651, Cedex 13, France;Leibniz Institute for Age Research/Fritz Lipmann Institute, Beutenbergstraße 11, Jena, D-07745, Germany;Molecular Neuroimmunology, Department of Neurology, University of Heidelberg, Im Neuenheimer Feld 400, Heidelberg, 69120, Germany;Department of Biochemistry and Molecular Biology, The University of Texas Medical School at Houston, 6431 Fannin Street, Houston 77030, TX, USA;Institute of Experimental Immunology, affiliated to Euroimmun AG, Seekamp 31, Lübeck, 23560, Germany;Institut d’ Investigació Biomèdica August Pi i Sunyer (IDIBAPS), Villarroel 170, Barcelona 08036, Spain | |
| 关键词: OPHN1L); Oligophrenin-1-like protein; GRAF1; GRAF; GTPase regulator associated with focal adhesion kinase pp125; Rho GTPase activating protein 26 (ARHGAP26; Purkinje cells; SCA29); SCA15; PPP1R94; CLA4; ACV; INSP3R1; IP3R1; IP3RI; Inositol 1,4,5-trisphosphate receptor type 1 (ITPR1; Autoimmune cerebellar ataxia; Autoantibodies; Anti-Sj; Anti-Ca; | |
| Others : 1149924 DOI : 10.1186/s12974-014-0206-3 |
|
| received in 2014-10-30, accepted in 2014-11-22, 发布年份 2014 | |
PDF
|
|
【 摘 要 】
We report on a serum autoantibody associated with cerebellar ataxia. Immunohistochemical studies of sera from four patients referred for autoantibody testing revealed binding of high-titer (up to 1:5,000) IgG antibodies, mainly IgG1, to the molecular layer, Purkinje cell layer, and white matter on mouse, rat, porcine, and monkey cerebellum sections. The antibody bound to PC somata, dendrites, and axons, resulting in a binding pattern similar to that reported for anti-Ca/anti-ARHGAP26, but did not react with recombinant ARHGAP26. Extensive control studies were performed to rule out a broad panel of previously described paraneoplastic and non-paraneoplastic anti-neural autoantibodies. The characteristic binding pattern as well as double staining experiments suggested inositol 1,4,5-trisphosphate receptor type 1 (ITPR1) as the target antigen. Verification of the antigen included specific neutralization of the tissue reaction following preadsorption with ITPR1 (but not ARHGAP26) and a dot-blot assay with purified ITPR1 protein. By contrast, anti-ARHGAP26-positive sera did not bind to ITPR1. In a parallel approach, a combination of histoimmunoprecipitation and mass spectrometry also identified ITPR1 as the target antigen. Finally, a recombinant cell-based immunofluorescence assay using HEK293 cells expressing ITPR1 and ARHGAP26, respectively, confirmed the identification of ITPR1. Mutations of ITPR1 have previously been implicated in spinocerebellar ataxia with and without cognitive decline. Our findings suggest a role of autoimmunity against ITPR1 in the pathogenesis of autoimmune cerebellitis and extend the panel of diagnostic markers for this disease.
【 授权许可】
2014 Jarius et al.; licensee BioMed Central.
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| 20150405113826895.pdf | 3130KB | ||
| Figure 9. | 74KB | Image | |
| Figure 8. | 18KB | Image | |
| Figure 7. | 197KB | Image | |
| 20150614102957888.pdf | 707KB | ||
| Figure 5. | 55KB | Image | |
| Figure 4. | 140KB | Image | |
| Figure 3. | 278KB | Image | |
| Figure 3. | 69KB | Image | |
| Figure 1. | 229KB | Image |
【 图 表 】
Figure 1.
Figure 3.
Figure 3.
Figure 4.
Figure 5.
Figure 7.
Figure 8.
Figure 9.
【 参考文献 】
- [1]Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, Honnorat J, Smitt PS, Vedeler C, Verschuuren JJ, Vincent A, Voltz R: Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 2004, 75:1135-1140.
- [2]Voltz R: Paraneoplastic neurological syndromes: an update on diagnosis, pathogenesis, and therapy. Lancet Neurol 2002, 1:294-305.
- [3]Graus F, Keime-Guibert F, Rene R, Benyahia B, Ribalta T, Ascaso C, Escaramis G, Delattre JY: Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain 2001, 124:1138-1148.
- [4]Pittock SJ, Lucchinetti CF, Lennon VA: Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments. Ann Neurol 2003, 53:580-587.
- [5]Peterson K, Rosenblum MK, Kotanides H, Posner JB: Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurology 1992, 42:1931-1937.
- [6]Yu Z, Kryzer TJ, Griesmann GE, Kim K, Benarroch EE, Lennon VA: CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol 2001, 49:146-154.
- [7]Honnorat J, Antoine JC, Belin MF: Are the “newly discovered” paraneoplastic anticollapsin response-mediator protein 5 antibodies simply anti-CV2 antibodies? Ann Neurol 2001, 50:688-691.
- [8]Trotter JL, Hendin BA, Osterland CK: Cerebellar degeneration with Hodgkin disease: an immunological study. Arch Neurol 1976, 33:660-661.
- [9]Bataller L, Wade DF, Graus F, Stacey HD, Rosenfeld MR, Dalmau J: Antibodies to Zic4 in paraneoplastic neurologic disorders and small-cell lung cancer. Neurology 2004, 62:778-782.
- [10]Sabater L, Bataller L, Carpentier AF, Aguirre-Cruz ML, Saiz A, Benyahia B, Dalmau J, Graus F: Protein kinase Cgamma autoimmunity in paraneoplastic cerebellar degeneration and non-small-cell lung cancer. J Neurol Neurosurg Psychiatry 2006, 77:1359-1362.
- [11]Sillevis Smitt P, Kinoshita A, De Leeuw B, Moll W, Coesmans M, Jaarsma D, Henzen-Logmans S, Vecht C, De Zeeuw C, Sekiyama N, Nakanishi S, Shigemoto R: Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor. N Engl J Med 2000, 342:21-27.
- [12]Coesmans M, Smitt PA, Linden DJ, Shigemoto R, Hirano T, Yamakawa Y, van Alphen AM, Luo C, van der Geest JN, Kros JM, Gaillard CA, Frens MA, de Zeeuw CI: Mechanisms underlying cerebellar motor deficits due to mGluR1-autoantibodies. Ann Neurol 2003, 53:325-336.
- [13]Vernino S, Lennon VA: New Purkinje cell antibody (PCA-2): marker of lung cancer-related neurological autoimmunity. Ann Neurol 2000, 47:297-305.
- [14]Chan KH, Vernino S, Lennon VA: ANNA-3 anti-neuronal nuclear antibody: marker of lung cancer-related autoimmunity. Ann Neurol 2001, 50:301-311.
- [15]Hoftberger R, Sabater L, Velasco F, Ciordia R, Dalmau J, Graus F: Carbonic anhydrase-related protein VIII antibodies and paraneoplastic cerebellar degeneration. Neuropathol Appl Neurobiol 2014, 40:650-653.
- [16]Bataller L, Sabater L, Saiz A, Serra C, Claramonte B, Graus F: Carbonic anhydrase-related protein VIII: autoantigen in paraneoplastic cerebellar degeneration. Ann Neurol 2004, 56:575-579.
- [17]Graus F, Lang B, Pozo-Rosich P, Saiz A, Casamitjana R, Vincent A: P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer. Neurology 2002, 59:764-766.
- [18]Hadjivassiliou M, Aeschlimann P, Strigun A, Sanders DS, Woodroofe N, Aeschlimann D: Autoantibodies in gluten ataxia recognize a novel neuronal transglutaminase. Ann Neurol 2008, 64:332-343.
- [19]Hadjivassiliou M: Primary autoimmune cerebellar ataxia (PACA). Adv Clin Neurosci Rehabil 2010, 9:8-11.
- [20]Shiihara T, Kato M, Konno A, Takahashi Y, Hayasaka K: Acute cerebellar ataxia and consecutive cerebellitis produced by glutamate receptor delta2 autoantibody. Brain Dev 2007, 29:254-256.
- [21]Shimokaze T, Kato M, Yoshimura Y, Takahashi Y, Hayasaka K: A case of acute cerebellitis accompanied by autoantibodies against glutamate receptor delta2. Brain Dev 2007, 29:224-226.
- [22]Zuliani L, Sabater L, Saiz A, Baiges JJ, Giometto B, Graus F: Homer 3 autoimmunity in subacute idiopathic cerebellar ataxia. Neurology 2007, 68:239-240.
- [23]Honnorat J, Saiz A, Giometto B, Vincent A, Brieva L, de Andres C, Maestre J, Fabien N, Vighetto A, Casamitjana R, Thivolet C, Tavolato B, Antoine J, Trouillas P, Graus F: Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol 2001, 58:225-230.
- [24]Rakocevic G, Raju R, Semino-Mora C, Dalakas MC: Stiff person syndrome with cerebellar disease and high-titer anti-GAD antibodies. Neurology 2006, 67:1068-1070.
- [25]Lancaster E, Lai M, Peng X, Hughes E, Constantinescu R, Raizer J, Friedman D, Skeen MB, Grisold W, Kimura A: Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol 2010, 9:67-76.
- [26]Jarius S, Steinmeyer F, Knobel A, Streitberger K, Hotter B, Horn S, Heuer H, Schreiber SJ, Wilhelm T, Trefzer U, Wildemann B, Ruprecht K: GABAB receptor antibodies in paraneoplastic cerebellar ataxia. J Neuroimmunol 2013, 256:94-96.
- [27]Mundiyanapurath S, Jarius S, Probst C, Stocker W, Wildemann B, Bosel J: GABA-B-receptor antibodies in paraneoplastic brainstem encephalitis. J Neuroimmunol 2013, 259:88-91.
- [28]Balint B, Jarius S, Nagel S, Haberkorn U, Probst C, Blocker IM, Bahtz R, Komorowski L, Stocker W, Kastrup A, Kuthe M, Meinck HM: Progressive encephalomyelitis with rigidity and myoclonus: a new variant with DPPX antibodies. Neurology 2014, 82:1521-1528.
- [29]Boronat A, Gelfand JM, Gresa-Arribas N, Jeong H-Y, Walsh M, Roberts K, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R, Graus F, Rudy B, Dalmau J: Encephalitis and antibodies to DPPX, a subunit of Kv4.2 potassium channels. Ann Neurol 2013, 73(1):120-128.
- [30]Jarius S, Wandinger KP, Horn S, Heuer H, Wildemann B: A new Purkinje cell antibody (anti-Ca) associated with subacute cerebellar ataxia: immunological characterization. J Neuroinflammation 2010, 7:21. BioMed Central Full Text
- [31]Jarius S, Martinez-Garcia P, Hernandez AL, Brase JC, Borowski K, Regula JU, Meinck HM, Stocker W, Wildemann B, Wandinger KP: Two new cases of anti-Ca (anti-ARHGAP26/GRAF) autoantibody-associated cerebellar ataxia. J Neuroinflammation 2013, 10:7. BioMed Central Full Text
- [32]Doss S, Nümann A, Ziegler A, Siebert E, Borowski K, Stöcker W, Prüss H, Wildemann B, Endres M, Jarius S: Anti-Ca/anti-ARHGAP26 antibodies associated with cerebellar atrophy and cognitive decline. J Neuroimmunol 2014, 267:102-104.
- [33]Jarius S, Wildemann B: Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature. Brain Pathol 2013, 23:661-683.
- [34]Ludtke SJ, Tran TP, Ngo QT, Moiseenkova-Bell VY, Chiu W, Serysheva II: Flexible architecture of IP3R1 by Cryo-EM. Structure 2011, 19:1192-1199.
- [35]Koy C, Mikkat S, Raptakis E, Sutton C, Resch M, Tanaka K, Glocker MO: Matrix-assisted laser desorption/ionization-quadrupole ion trap-time of flight mass spectrometry sequencing resolves structures of unidentified peptides obtained by in-gel tryptic digestion of haptoglobin derivatives from human plasma proteomes. Proteomics 2003, 3:851-858.
- [36]Graus F, Dalmau J, Valldeoriola F, Ferrer I, Rene R, Marin C, Vecht CJ, Arbizu T, Targa C, Moll JW: Immunological characterization of a neuronal antibody (anti-Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin’s disease. J Neuroimmunol 1997, 74:55-61.
- [37]de Graaff E, Maat P, Hulsenboom E, van den Berg R, van den Bent M, Demmers J, Lugtenburg PJ, Hoogenraad CC, Sillevis Smitt P: Identification of delta/notch-like epidermal growth factor-related receptor as the Tr antigen in paraneoplastic cerebellar degeneration. Ann Neurol 2012, 71:815-824.
- [38]Sillevis Smitt P: Paraneoplastic neurological syndromes. Lancet Neurol 2002, 1:408.
- [39]Berridge MJ: Inositol trisphosphate and calcium signalling. Nature 1993, 361:315-325.
- [40]Hirota J, Ando H, Hamada K, Mikoshiba K: Carbonic anhydrase-related protein is a novel binding protein for inositol 1,4,5-trisphosphate receptor type 1. Biochem J 2003, 372:435-441.
- [41]Waters P, Jarius S, Littleton E, Leite MI, Jacob S, Gray B, Geraldes R, Vale T, Jacob A, Palace J, Maxwell S, Beeson D, Vincent A: Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis. Arch Neurol 2008, 65:913-919.
- [42]Hinson SR, Pittock SJ, Lucchinetti CF, Roemer SF, Fryer JP, Kryzer TJ, Lennon VA: Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology 2007, 69:2221-2231.
- [43]van de Leemput J, Chandran J, Knight MA, Holtzclaw LA, Scholz S, Cookson MR, Houlden H, Gwinn-Hardy K, Fung HC, Lin X, Hernandez D, Simon-Sanchez J, Wood NW, Giunti P, Rafferty I, Hardy J, Storey E, Gardner RJ, Forrest SM, Fisher EM, Russell JT, Cai H, Singleton AB: Deletion at ITPR1 underlies ataxia in mice and spinocerebellar ataxia 15 in humans. PLoS Genet 2007, 3:e108.
- [44]Huang L, Chardon JW, Carter MT, Friend KL, Dudding TE, Schwartzentruber J, Zou R, Schofield PW, Douglas S, Bulman DE, Boycott KM: Missense mutations in ITPR1 cause autosomal dominant congenital nonprogressive spinocerebellar ataxia. Orphanet J Rare Dis 2012, 7:67. BioMed Central Full Text
- [45]Matsumoto M, Nakagawa T, Inoue T, Nagata E, Tanaka K, Takano H, Minowa O, Kuno J, Sakakibara S, Yamada M, Yoneshima H, Miyawaki A, Fukuuchi Y, Furuichi T, Okano H, Mikoshiba K, Noda T: Ataxia and epileptic seizures in mice lacking type 1 inositol 1,4,5-trisphosphate receptor. Nature 1996, 379:168-171.
- [46]Tanimura A, Tojyo Y, Turner RJ: Evidence that type I, II, and III inositol 1,4,5-trisphosphate receptors can occur as integral plasma membrane proteins. J Biol Chem 2000, 275:27488-27493.
- [47]Lischka FW, Zviman MM, Teeter JH, Restrepo D: Characterization of inositol-1,4,5-trisphosphate-gated channels in the plasma membrane of rat olfactory neurons. Biophys J 1999, 76:1410-1422.
- [48]Vermassen E, Parys JB, Mauger JP: Subcellular distribution of the inositol 1,4,5-trisphosphate receptors: functional relevance and molecular determinants. Biol Cell 2004, 96:3-17.
- [49]Taylor CW, Dellis O: Plasma membrane IP3 receptors. Biochem Soc Trans 2006, 34:910-912.
- [50]Dellis O, Dedos SG, Tovey SC, Taufiq Ur R, Dubel SJ, Taylor CW: Ca2+ entry through plasma membrane IP3 receptors. Science 2006, 313:229-233.
- [51]Jarius S, Paul F, Franciotta D, Waters P, Zipp F, Hohlfeld R, Vincent A, Wildemann B: Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. Nat Clin Pract Neurol 2008, 4:202-214.
- [52]Jarius S, Franciotta D, Bergamaschi R, Wright H, Littleton E, Palace J, Hohlfeld R, Vincent A: NMO-IgG in the diagnosis of neuromyelitis optica. Neurology 2007, 68:1076-1077.
- [53]Jarius S, Aboul-Enein F, Waters P, Kuenz B, Hauser A, Berger T, Lang W, Reindl M, Vincent A, Kristoferitsch W: Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain 2008, 131:3072-3080.
- [54]Vincent A, Lang B, Newsom-Davis J: Autoimmunity to the voltage-gated calcium channel underlies the Lambert-Eaton myasthenic syndrome, a paraneoplastic disorder. Trends Neurosci 1989, 12:496-502.
- [55]Graus F, Illa I, Agusti M, Ribalta T, Cruz-Sanchez F, Juarez C: Effect of intraventricular injection of an anti-Purkinje cell antibody (anti-Yo) in a guinea pig model. J Neurol Sci 1991, 106:82-87.
- [56]Tanaka K, Tanaka M, Igarashi S, Onodera O, Miyatake T, Tsuji S: Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe combined immunodeficiency mice. Clin Neurol Neurosurg 1995, 97:101-105.
- [57]Tanaka K, Tanaka M, Onodera O, Igarashi S, Miyatake T, Tsuji S: Passive transfer and active immunization with the recombinant leucine-zipper (Yo) protein as an attempt to establish an animal model of paraneoplastic cerebellar degeneration. J Neurol Sci 1994, 127:153-158.
- [58]Tanaka M, Maruyama Y, Sugie M, Motizuki H, Kamakura K, Tanaka K: Cytotoxic T cell activity against peptides of Hu protein in anti-Hu syndrome. J Neurol Sci 2002, 201:9-12.
- [59]Benyahia B, Liblau R, Merle-Beral H, Tourani JM, Dalmau J, Delattre JY: Cell-mediated autoimmunity in paraneoplastic neurological syndromes with anti-Hu antibodies. Ann Neurol 1999, 45:162-167.
- [60]Rousseau A, Benyahia B, Dalmau J, Connan F, Guillet JG, Delattre JY, Choppin J: T cell response to Hu-D peptides in patients with anti-Hu syndrome. J Neurooncol 2005, 71:231-236.
- [61]Voltz R, Dalmau J, Posner JB, Rosenfeld MR: T-cell receptor analysis in anti-Hu associated paraneoplastic encephalomyelitis. Neurology 1998, 51:1146-1150.
PDF